Stocks and Investing Stocks and Investing
Tue, February 7, 2012
Mon, February 6, 2012

CHINA MEDICAL TECH-SPON ADR (NASDAQ:CMED), Down By 46.97% ($1.63) From $3.470 After BUYINS.NET Report Predicted Stock Would Go


Published on 2012-02-06 13:40:47 - WOPRAI
  Print publication without navigation


February 6, 2012 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a provider of unique trading technologies, released a report on Tuesday, January 17th 2012 stating that CHINA MEDICAL TECH-SPON ADR (NASDAQ:CMED) was expected to go Down due to the Bearish conditions presented in the following report. Click here to view the BUYINS.NET report: http://www.buyins.net/releases/?sym=cmed&id=231804

At the time this story was written, CHINA MEDICAL TECH-SPON ADR (NASDAQ:CMED) is Down By $1.63 (46.97%) since the BUYINS.NET report was released.

The movement of stock prices in the days and weeks leading to and following specific fundamental or technical events may follow a predictable pattern. Many companies stock price histories show random or unpredictable movements around certain events. But some seem to repeat the same pattern quarter after quarter, year after year. We use powerful computers to uncover those events and correlations to generate predictions with high probabilities of generating very specific returns within very specific time periods.

The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php

CHINA MEDICAL TECH-SPON ADR (NASDAQ:CMED) - China Medical Technologies, Inc., a medical device company, develops, manufactures, and markets advanced immunodiagnostic and molecular diagnostic products primarily in the Peoples Republic of China. The company offers IVD products, which utilize ECLIA technology, fluorescent in situ hybridization (FISH) technology, and surface plasmon resonance (SPR) technology to detect and monitor various diseases and disorders through the laboratory evaluation and analysis of blood, urine, or other body fluids. It offers ECLIA system, which includes ECLIA analyzer for detecting the minute levels of light triggered by combining reagents with body fluid samples to produce diagnostic results; and reagent kits for detecting and monitoring various types of diseases and disorders, including thyroid disorders, diabetes, hepatitis, SARS, Down syndrome, liver fibrosis, disorders related to reproduction and growth, and various types of tumors. The company also provides FISH imaging analysis system that enables medical practitioners to visualize and locate DNA sequences in human cells for identifying chromosomal abnormalities, using FISH technology; and offers FISH probes used for prenatal and cancer management. The FISH probes are used for the detection and monitoring the course of bladder cancer; treatment of breast cancer; prediction and diagnosis of cervical cancer; diagnosis and prognosis of various leukemias and multiple myeloma; detection of epidermal growth factor receptor abnormalities; detection of Trisomy 21, Trisomy 18, Trisomy 13, Turner syndrome, Trisomy X, XYY syndrome, DiGeorge syndrome, and triploidy; and diagnosis of prostate cancer. In addition, it offers HPV-DNA chips and SPR-based analysis system for the diagnosis of human papillomavirus (HPV) infection and genotyping of HPV. The company sells its products through distributors. China Medical Technologies, Inc. was founded in 1999 and is based in Beijing, the Peoples Republic of China.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor market-maker surveillance system tracking Level II market-makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 30 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies specifically for this report, but may have been compensated up to $1,200 per month in the past for unrelated data or report services. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net

Contributing Sources